The Accelerator Program for Discovery in Brain Disorders using Stem Cells (ADBS) is now the Rohini Nilekani Centre for Brain and Mind at NIMHANS. Visit our new website for the latest updates.

Our latest paper in Nature Scientific Reports is out!

Mahadevan, J., Pathak, A.K., Vemula, A. et al. Analysis of whole exome sequencing in severe mental illness hints at selection of brain development and immune related genes. Sci Rep 11, 21088 (2021)

Click here to visit the journal website

ADBS Walkthrough Video (Courtesy Science Gallery Bangalore)

What is ADBS?

Mental illnesses include well-recognized conditions such as schizophrenia, bipolar disorder, obsessive-compulsive disorder, addiction and dementia. Changes in the structure and function of the brain that result in mental illness are poorly understood. Neither do we understand why some individuals are more prone to developing mental illness than others. Understanding these underlying changes in the brain will likely lead to better methods to diagnose and treat mental illness.

The Accelerator program for Discovery in Brain disorders using Stem cells (ADBS) is a new scientific venture to understand mental illness by harnessing the power of sophisticated clinical investigations, modern human genetics, and stem cell technology.

ADBS was launched in 2016 under the joint stewardship of three institutions from Bangalore, India – the National Centre for Biological Sciences (NCBS), the Institute for Stem Cell Science and Regenerative Medicine (inStem) and the National Institute for Mental Health and Neurosciences (NIMHANS).

The ADBS program is supported by the Department of Biotechnology, Ministry of Science & Technology, Government of India and the Pratiksha Trust.

Mission

The mission of the ADBS is to nucleate a program of research to understand the development and mechanistic basis of common, serious psychiatric disorders in the Indian population. It is proposed to do this through a long-term, integrated and collaborative effort involving specialist clinicians from NIMHANS as well as scientists from NCBS/inStem with expertise in understanding the cellular and molecular analysis of biological processes. This application to the DBT, GoI is for a five-year proof of principle activity to nucleate this long-term effort. It is proposed under the umbrella of a future proposal to the Ministry of Health, GoI for a long-term support for research into psychiatric illness in the Indian population. 

In this application, we propose to set up a prospective, longitudinal cohort of patients with adult onset psychiatric disorders including at-risk subjects with genetic predisposition as well as asymptomatic controls. These cohorts will be followed from childhood/young adults over a period of twenty years. The members of the cohort will be subjected to a uniform set of clinical analysis and a biorepository will be set up using cellular material from these individuals. It is expected that deep interrogation of brain networks (via brain imaging and clinical electrophysiology) as well as sub-cellular networks using molecular and cellular analysis would lead to better mechanistic understanding of these disorders. These findings should lead to better diagnostic and therapeutic approaches for patients with psychiatric disorders as well as fundamental new insights into the function of the human brain.

Would you like to contribute to neuroscience research?

ADBS in the News

“Evolution of immune mechanisms can shape genetic risk of mental illness”

 
 

The Hindu, November 28th, 2021

 

 

Click to read mode

“Excess alcohol intake can irreversibly damage DNA: NIMHANS Study”

 

The Hindu, February 13th , 2021

 
Click to read more